Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar SGMChasER (92.74) Submitted: 7/9/2008 11:12:09 PM : Outperform Start Price: $31.11 MRK Score: +11.16

Buy what you know.

Report this Post Reply

Featured Broker Partners


Advertisement